2022
DOI: 10.31744/einstein_journal/2022ao6985
|View full text |Cite
|
Sign up to set email alerts
|

Laboratory variables as predictors of progression in gastroenteropancreatic neuroendocrine tumors in different lines of antineoplastic treatments

Abstract: Objective: To determine the association of red cell blood counts, and liver panel tests to predict outcomes in patients with gastroenteropancreatic neuroendocrine tumors who underwent systemic antineoplastic treatments. Methods: Patients with gastroenteropancreatic neuroendocrine tumors in systemic treatment were assessed according to laboratory tests within the same period. Progression free survival was determined by the period between the beginning of treatment and th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Neuroendocrine tumors (NETs) are malignancies of endocrine origin with an incidence perhaps as low as 2:100,000 [1]. These lesions derive from neuroendocrine cells which may potentially arise anywhere in the body; detection is difficult due to long periods of quiescence.…”
Section: Introductionmentioning
confidence: 99%
“…Neuroendocrine tumors (NETs) are malignancies of endocrine origin with an incidence perhaps as low as 2:100,000 [1]. These lesions derive from neuroendocrine cells which may potentially arise anywhere in the body; detection is difficult due to long periods of quiescence.…”
Section: Introductionmentioning
confidence: 99%